Due to planned maintenance, customers will be unable to make credit card purchases from Sunday midnight to 9 AM Eastern Time, November 23, December 7, and December 14. Thank you for your patience as we continue to improve our infrastructure to better serve you.

Genoptix, Inc.Carlsbad, CA, United States (NASDAQ (GM): GXDX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Genoptix Financial Statements

Genoptix Financial Information

Company Type Public
Single Location
Fiscal Year-End December
Edgar Online logo
This data is provided as per license from EDGAR Online

Genoptix Income Statement

  2007 2006 2005
Revenue ($ mil.) 59.3 24.0 5.2
Gross Profit ($ mil.) 35.2 10.9 0.0
Operating Income ($ mil.) 13.0 (3.9) (9.1)
Total Net Income ($ mil.) 13.4 (3.8) (9.2)
Diluted EPS (Net Income) 0.78 (33.74) (111.33)
More Genoptix financial information

Genoptix Stock Quote & Chart

11/21/08 16:00:12 EST • NASDAQ • 29.89 • Decreased by -1.4700 • Decreased by -4.6875 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Genoptix Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 10.24 0.90 1.56
Price/Earnings Ratio 30.62 18.06 15.82
Price/Book Ratio 6.70 2.13 1.52
Price/Cash Flow Ratio 46.35 8.15 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Genoptix Financial Ratios

Genoptix Competitive Intelligence

Bio-Reference Labs Genzyme LabCorp
Annual Sales ($ mil.) 250.4 3,813.5 4,068.2
Employees 1,648 10,000 26,000
Market Cap ($ mil.) 371.6 22,314.3 8,037.0

Competitive Landscape